In Chicago, Jeffrey Hubbell, a Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago, received the Society for Biomaterials’ 2017 Founders Award. Hubbell’s immunotherapy work focuses on designing biomaterials for stimulating the immune system, fighting infections, and even shutting off some autoimmune responses that cause diseases like Type 1 diabetes. Hubbell has co-founded five companies including ClostraBio, a food allergy treatment startup, Kuros Biosciences, a developer of biomaterials technology for surgical sealants, QGel, a developer of biomaterials for cell cultures, Anokion, a developer of autoimmune technology, and Kanyos Bio, a tech developer for Type 1 diabetes and celiac disease. The award is given every year to someone who, according to the University of Chicago, has made “long-term, landmark contributions to the discipline of biomaterials.”
Home Biomaterials Society for Biomaterials Awards 2017 Founders Award to University of Chicago Professor
Latest article
Planet-friendly pyrotechnics: Fireworks industry adopts renewable materials
In the United Kingdom, Chorlton Fireworks is leading a fireworks industry charge to replace plastic components with biodegradable materials where possible. Chorlton is already...
Popular Nivea skin cream gets natural ingredient makeover
In Germany, Beiersdorf has launched a line extension for its best-selling Nivea Crème that is 99% natural-origin ingredients—a feat that took six years of...
Argentinian students win Industria Inspira contest with sodium alginate water capsules
In Argentina, four students have won the Industria Inspira national contest for creating edible and biodegradable capsules that holding drinking water.
Made of sodium...